Cargando…
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) was first reported in China in December 2019, various variants have been identified in different areas of the world such as United Kingdom (alpha), South Africa (beta and omicron), Brazil (gamma), and India (delta). Some of...
Autores principales: | Hikichi, Tetsuro, Sakamoto, Michiko, Harada, Makiko, Saito, Maki, Yamane, Yuka, Tokumura, Kimihisa, Nakamura, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807680/ https://www.ncbi.nlm.nih.gov/pubmed/35110673 http://dx.doi.org/10.1038/s10038-022-01013-4 |
Ejemplares similares
-
Correction: Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides
por: Hikichi, Tetsuro, et al.
Publicado: (2022) -
Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes
Publicado: (1989) -
Motifs and supermotifs for MHC class II binding peptides
Publicado: (1995) -
Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation
por: Masuda, Ai, et al.
Publicado: (2007) -
Prediction of MHC class I binding peptides, using SVMHC
por: Dönnes, Pierre, et al.
Publicado: (2002)